Premium
INTRAVENOUS HIGH DOSE METHOTREXATE AS CENTRAL NERVOUS SYSTEM (CNS) PROPHYLAXIS IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) WITH HIGH RISK FOR CNS PROGRESSION
Author(s) -
Villarreal J. A.,
Rovira J.,
Franch M.,
Encuentra M.,
Blazevic D.,
Rodriguez M.,
Kelleger N.,
Martín S.,
Oliveira A. C.,
Domingo Domenech E.,
Ribera J. M.,
Sureda A.,
Sancho J. M.,
Escoda L.,
GonzálezBarca E.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.46_2881
Subject(s) - medicine , methotrexate , diffuse large b cell lymphoma , lymphoma , antifolate , primary central nervous system lymphoma , surgery , oncology , gastroenterology , antimetabolite